Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-04-22 00:00:00 ET · period of report 2024-04-18 · accession 0001510281-24-000250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-04-22 | 2024-04-18+ | HQL | Weinstein Boaz | 10% | P - Purchase | $12.81 | +124.2K | 2.74M | +5% | +$1.59M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-18 | P | A | 81,738 | $12.80 | 2,694,511 | I - | — | — | |
| 2 | Common | Common Stock | 2024-04-19 | P | A | 42,459 | $12.84 | 2,736,970 | I - | — | — |